Fortress Biotech

Fortress Biotech, Inc. is a biopharmaceutical company headquartered in Surfside, Florida. The company employs around 30 people and reports annual revenue exceeding $10,000. Fortress Biotech focuses on acquiring, developing, and commercializing pharmaceutical products with high growth potential. They offer a diverse portfolio of seven marketed prescription drugs and over 25 programs currently in development. These programs span six key therapeutic areas, including oncology, rare diseases, and gene therapy. Fortress Biotech aims to deliver value to shareholders by strategically expanding its product portfolio across these high-impact therapeutic areas. Fortress Biotech differentiates itself through a streamlined operating structure that promotes efficient drug development. The company's success is driven by a team of experienced business development professionals who leverage their expertise in the biopharmaceutical industry to identify and acquire promising product opportunities. To maximize the potential of its product pipeline, Fortress Biotech has established partnerships with world-renowned academic research institutions and biopharmaceutical companies. These collaborations include partnerships with Alexion Pharmaceuticals, Inc., AstraZeneca, City of Hope, Fred Hutchinson Cancer Research Center, St. Jude Children's Research Hospital, and Nationwide Children’s Hospital. For more information about Fortress Biotech, please visit their website at fortressbiotech.com.